These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of 5-HT Humby T; Smith GE; Small R; Davies W; Carter J; Bentley CA; Winstanley CA; Rogers RD; Wilkinson LS Psychopharmacology (Berl); 2020 Jun; 237(6):1745-1756. PubMed ID: 32123974 [TBL] [Abstract][Full Text] [Related]
3. A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat. Pratt WE; Clissold KA; Lin P; Cain AE; Ciesinski AF; Hopkins TR; Ilesanmi AO; Kelly EA; Pierce-Messick Z; Powell DS; Rosner IA Brain Res; 2016 Oct; 1648(Pt A):54-68. PubMed ID: 27431937 [TBL] [Abstract][Full Text] [Related]
4. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications. Greenshaw AJ; Silverstone PH Drugs; 1997 Jan; 53(1):20-39. PubMed ID: 9010647 [TBL] [Abstract][Full Text] [Related]
6. Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action. Fernández-Guasti A; Hong E; López-Rubalcava C Psychopharmacology (Berl); 1992; 107(1):61-8. PubMed ID: 1350351 [TBL] [Abstract][Full Text] [Related]